Food and Drug Administration's Position on Commonly Injected Biologic Materials in Orthopaedic Surgery: Response

Am J Sports Med. 2022 Sep;50(11):NP43-NP44. doi: 10.1177/03635465221116364. Epub 2022 Aug 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Products* / therapeutic use
  • Humans
  • Orthopedic Procedures*
  • Orthopedics*
  • Pharmaceutical Preparations
  • United States
  • United States Food and Drug Administration

Substances

  • Biological Products
  • Pharmaceutical Preparations